Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Merck & Co., Inc. Stock Update: ANTIPODES PARTNERS Ltd Sells Stake

Guavy AI Editorial Team
Instruments
MRK
Share

Merck & Co., Inc.'s (NYSE:MRK) stock has been affected by various market movements in recent times. One of the key updates is that ANTIPODES PARTNERS Ltd decreased its stake in MRK shares by 23.9% during the 2nd quarter, as per its most recent Form 13F filing with the SEC.

The fund owned 1,097,509 shares of Merck & Co., Inc.'s stock after selling 343,757 shares during the period. This comprises about 2.6% of ANTIPODES PARTNERS Ltd's investment portfolio, making MRK its 11th biggest holding.

Merck & Co., Inc.'s holdings in Merck & Co., Inc. were worth $141,030,000 at the end of the most recent reporting period.

More on Stocks

Stocks 2m ago

Will Soccer's US Boom End with the World Cup?

Stocks 2m ago

Chowmainsoft Expands Control4 Integration with Google TV and Cast Drivers

Stocks 2m ago

$700 Million Settlement Approved in Multi-State Lawsuit Against Google

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy